CN Stock MarketDetailed Quotes

600721 Xinjiang Bai Hua Cun Pharma Tech

Watchlist
  • 6.05
  • +0.55+10.00%
Market Closed Jul 12 15:00 CST
2.31BMarket Cap85.21P/E (TTM)

Xinjiang Bai Hua Cun Pharma Tech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
20.03%90.88M
5.54%369.28M
3.65%265.71M
2.11%167.21M
28.77%75.71M
24.36%349.88M
39.04%256.36M
36.70%163.76M
24.40%58.8M
232.84%281.35M
Operating revenue
20.03%90.88M
5.54%369.28M
3.65%265.71M
2.11%167.21M
28.77%75.71M
24.36%349.88M
39.04%256.36M
36.70%163.76M
24.40%58.8M
232.84%281.35M
Other operating revenue
----
-12.76%3.06M
----
-22.49%2.55M
----
8.86%3.51M
----
35.85%3.29M
----
-4.66%3.22M
Total operating cost
5.02%68.38M
-6.89%301.19M
-3.49%220.18M
-0.34%142.33M
20.16%65.12M
30.58%323.49M
36.67%228.14M
29.30%142.81M
23.64%54.19M
-21.49%247.74M
Operating cost
12.26%43.39M
-10.48%188.19M
-8.20%137.6M
-7.00%89M
22.01%38.65M
24.61%210.22M
30.92%149.9M
26.19%95.7M
21.95%31.68M
-23.81%168.7M
Operating tax surcharges
29.82%1.2M
9.46%5.25M
2.67%3.44M
-11.54%2.22M
-22.15%927.58K
3.13%4.79M
6.96%3.35M
11.81%2.51M
25.42%1.19M
16.18%4.65M
Operating expense
-11.89%2.31M
-14.79%13.15M
-7.87%8.36M
3.34%5.5M
-0.77%2.62M
96.12%15.43M
107.37%9.07M
108.98%5.32M
130.88%2.64M
87.49%7.87M
Administration expense
-6.26%15.8M
-3.41%63.6M
3.16%50.15M
16.01%33.44M
17.72%16.86M
7.27%65.85M
16.28%48.62M
3.90%28.82M
-2.53%14.32M
-2.25%61.38M
Financial expense
-293.16%-324.38K
-214.01%-866.17K
-590.69%-582.79K
-1,512.71%-424.62K
-1,329.71%-82.51K
-158.35%-275.84K
41.98%-84.38K
78.31%-26.33K
109.41%6.71K
-100.63%-106.77K
-Interest expense (Financial expense)
----
----
----
----
----
138.43%112.58K
394.20%112.58K
1,233.29%112.58K
--63.19K
-93.72%47.22K
-Interest Income (Financial expense)
-185.62%-361.03K
-95.78%-1.02M
-171.73%-758.73K
-192.56%-513.77K
-64.36%-126.4K
-135.80%-521.76K
-28.53%-279.22K
-8.23%-175.61K
15.82%-76.9K
0.39%-221.27K
Research and development
-2.26%6M
15.96%31.87M
22.69%21.2M
20.18%12.6M
41.02%6.14M
423.36%27.48M
431.15%17.28M
377.97%10.48M
282.09%4.35M
-14.12%5.25M
Credit Impairment Loss
-226.00%-883.66K
-108.87%-4.3M
-174.55%-2.57M
-135.70%-1.85M
48.65%-271.06K
-42.89%-2.06M
-11.31%-937.48K
17.86%-785.94K
-87.05%-527.92K
56.50%-1.44M
Asset Impairment Loss
97.58%-89.83K
14.07%-49.33M
-101.89%-25.45M
-44.71%-9.56M
-109.73%-3.71M
-208.16%-57.41M
-50.12%-12.61M
-10.54%-6.6M
14.03%-1.77M
87.51%-18.63M
Other net revenue
83.77%-514.5K
12.25%-50.13M
-73.70%-24.76M
-12.67%-9.83M
-22.24%-3.17M
-290.86%-57.13M
-136.93%-14.26M
-121.42%-8.72M
-38.59%-2.59M
121.41%29.93M
Fair value change income
----
-9.27%704.94K
----
----
----
-69.25%776.96K
----
----
----
-54.03%2.53M
Invest income
-47.56%254.72K
263.16%1.25M
203.76%2.37M
145.11%947.6K
170.93%485.72K
63.30%-766K
-190.66%-2.28M
-201.36%-2.1M
-1,663.24%-684.74K
-212.28%-2.09M
-Including: Investment income associates
-104.56%-13.4K
78.86%-315.5K
152.15%1.43M
117.86%420.32K
138.27%293.69K
36.58%-1.49M
-184.21%-2.74M
-197.47%-2.35M
-42,670.17%-767.43K
-338.27%-2.35M
Asset deal income
363.46%22.39K
1,144.34%14.29K
--4.83K
--4.83K
--4.83K
-76.23%1.15K
----
----
----
-99.12%4.83K
Other revenue
-43.29%181.87K
-34.08%1.53M
-43.32%891.38K
-18.16%626.34K
-17.42%320.74K
-95.32%2.32M
-96.77%1.57M
-98.42%765.3K
-7.57%388.4K
926.89%49.56M
Operating profit
196.02%21.98M
158.41%17.96M
48.80%20.77M
23.16%15.05M
269.17%7.43M
-148.38%-30.74M
-75.09%13.96M
-75.59%12.22M
28.82%2.01M
117.14%63.54M
Add:Non operating Income
228.88%98.58K
17.14%124.8K
-75.06%64.05K
-81.86%43.17K
2,631.86%29.97K
-48.59%106.54K
-20.90%256.79K
-7.77%237.99K
-99.50%1.1K
-99.71%207.25K
Less:Non operating expense
-0.51%59.6K
7.93%1.6M
-59.42%490.34K
-48.22%417.32K
734.52%59.91K
-5.83%1.48M
909.93%1.21M
10,666.93%806K
-55.48%7.18K
-89.62%1.57M
Total profit
197.75%22.02M
151.32%16.48M
56.40%20.35M
25.95%14.68M
268.80%7.4M
-151.65%-32.12M
-76.88%13.01M
-76.84%11.66M
13.74%2.01M
119.70%62.18M
Less:Income tax cost
91.40%1.36M
33.85%3.51M
31.86%2.65M
25.21%1.68M
13.13%708.61K
13.93%2.62M
51.72%2.01M
275.86%1.34M
-7.84%626.38K
-43.68%2.3M
Net profit
209.02%20.66M
FLtoP12.97M
60.90%17.69M
26.04%13M
384.94%6.69M
SL-34.74M
-79.98%11M
-79.36%10.31M
27.28%1.38M
FLtoP59.87M
Net profit from continuing operation
209.02%20.66M
137.34%12.97M
60.90%17.69M
26.04%13M
384.94%6.69M
-158.02%-34.74M
-79.98%11M
-79.36%10.31M
27.28%1.38M
118.72%59.87M
Less:Minority Profit
----
----
----
----
----
-41.74%27.46K
----
-19.12%19.11K
-40.90%6.73K
4,627.99%47.14K
Net profit of parent company owners
209.02%20.66M
137.31%12.97M
60.90%17.69M
26.28%13M
387.32%6.69M
-158.11%-34.76M
-79.97%11M
-79.39%10.29M
28.00%1.37M
118.71%59.83M
Earning per share
Basic earning per share
205.65%0.0541
136.97%0.0342
59.73%0.0468
25.55%0.0344
378.38%0.0177
-157.99%-0.0925
-79.97%0.0293
-79.43%0.0274
27.59%0.0037
119.45%0.1595
Diluted earning per share
206.82%0.054
137.21%0.0342
59.93%0.0467
26.57%0.0343
388.89%0.0176
-157.62%-0.0919
-80.04%0.0292
-79.65%0.0271
24.14%0.0036
119.45%0.1595
Other composite income
38.81%-140K
-20.35%-228.79K
52.03%-190.11K
Other composite income of parent company owners
----
38.81%-140K
----
----
----
-20.35%-228.79K
----
----
----
52.03%-190.11K
Total composite income
209.02%20.66M
136.70%12.83M
60.90%17.69M
26.04%13M
384.94%6.69M
-158.59%-34.97M
-79.98%11M
-79.36%10.31M
1.38M
118.64%59.68M
Total composite income of parent company owners
209.02%20.66M
136.67%12.83M
60.90%17.69M
26.28%13M
387.32%6.69M
-158.68%-34.99M
-79.97%11M
-79.39%10.29M
--1.37M
118.63%59.64M
Total composite income of minority owners
----
----
----
----
----
-41.74%27.46K
----
-19.12%19.11K
--6.73K
4,627.99%47.14K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Sigma Certified Public Accountants (Special General Partnership)
--
--
--
Sigma Certified Public Accountants (Special General Partnership)
--
--
--
Sigma Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 20.03%90.88M5.54%369.28M3.65%265.71M2.11%167.21M28.77%75.71M24.36%349.88M39.04%256.36M36.70%163.76M24.40%58.8M232.84%281.35M
Operating revenue 20.03%90.88M5.54%369.28M3.65%265.71M2.11%167.21M28.77%75.71M24.36%349.88M39.04%256.36M36.70%163.76M24.40%58.8M232.84%281.35M
Other operating revenue -----12.76%3.06M-----22.49%2.55M----8.86%3.51M----35.85%3.29M-----4.66%3.22M
Total operating cost 5.02%68.38M-6.89%301.19M-3.49%220.18M-0.34%142.33M20.16%65.12M30.58%323.49M36.67%228.14M29.30%142.81M23.64%54.19M-21.49%247.74M
Operating cost 12.26%43.39M-10.48%188.19M-8.20%137.6M-7.00%89M22.01%38.65M24.61%210.22M30.92%149.9M26.19%95.7M21.95%31.68M-23.81%168.7M
Operating tax surcharges 29.82%1.2M9.46%5.25M2.67%3.44M-11.54%2.22M-22.15%927.58K3.13%4.79M6.96%3.35M11.81%2.51M25.42%1.19M16.18%4.65M
Operating expense -11.89%2.31M-14.79%13.15M-7.87%8.36M3.34%5.5M-0.77%2.62M96.12%15.43M107.37%9.07M108.98%5.32M130.88%2.64M87.49%7.87M
Administration expense -6.26%15.8M-3.41%63.6M3.16%50.15M16.01%33.44M17.72%16.86M7.27%65.85M16.28%48.62M3.90%28.82M-2.53%14.32M-2.25%61.38M
Financial expense -293.16%-324.38K-214.01%-866.17K-590.69%-582.79K-1,512.71%-424.62K-1,329.71%-82.51K-158.35%-275.84K41.98%-84.38K78.31%-26.33K109.41%6.71K-100.63%-106.77K
-Interest expense (Financial expense) --------------------138.43%112.58K394.20%112.58K1,233.29%112.58K--63.19K-93.72%47.22K
-Interest Income (Financial expense) -185.62%-361.03K-95.78%-1.02M-171.73%-758.73K-192.56%-513.77K-64.36%-126.4K-135.80%-521.76K-28.53%-279.22K-8.23%-175.61K15.82%-76.9K0.39%-221.27K
Research and development -2.26%6M15.96%31.87M22.69%21.2M20.18%12.6M41.02%6.14M423.36%27.48M431.15%17.28M377.97%10.48M282.09%4.35M-14.12%5.25M
Credit Impairment Loss -226.00%-883.66K-108.87%-4.3M-174.55%-2.57M-135.70%-1.85M48.65%-271.06K-42.89%-2.06M-11.31%-937.48K17.86%-785.94K-87.05%-527.92K56.50%-1.44M
Asset Impairment Loss 97.58%-89.83K14.07%-49.33M-101.89%-25.45M-44.71%-9.56M-109.73%-3.71M-208.16%-57.41M-50.12%-12.61M-10.54%-6.6M14.03%-1.77M87.51%-18.63M
Other net revenue 83.77%-514.5K12.25%-50.13M-73.70%-24.76M-12.67%-9.83M-22.24%-3.17M-290.86%-57.13M-136.93%-14.26M-121.42%-8.72M-38.59%-2.59M121.41%29.93M
Fair value change income -----9.27%704.94K-------------69.25%776.96K-------------54.03%2.53M
Invest income -47.56%254.72K263.16%1.25M203.76%2.37M145.11%947.6K170.93%485.72K63.30%-766K-190.66%-2.28M-201.36%-2.1M-1,663.24%-684.74K-212.28%-2.09M
-Including: Investment income associates -104.56%-13.4K78.86%-315.5K152.15%1.43M117.86%420.32K138.27%293.69K36.58%-1.49M-184.21%-2.74M-197.47%-2.35M-42,670.17%-767.43K-338.27%-2.35M
Asset deal income 363.46%22.39K1,144.34%14.29K--4.83K--4.83K--4.83K-76.23%1.15K-------------99.12%4.83K
Other revenue -43.29%181.87K-34.08%1.53M-43.32%891.38K-18.16%626.34K-17.42%320.74K-95.32%2.32M-96.77%1.57M-98.42%765.3K-7.57%388.4K926.89%49.56M
Operating profit 196.02%21.98M158.41%17.96M48.80%20.77M23.16%15.05M269.17%7.43M-148.38%-30.74M-75.09%13.96M-75.59%12.22M28.82%2.01M117.14%63.54M
Add:Non operating Income 228.88%98.58K17.14%124.8K-75.06%64.05K-81.86%43.17K2,631.86%29.97K-48.59%106.54K-20.90%256.79K-7.77%237.99K-99.50%1.1K-99.71%207.25K
Less:Non operating expense -0.51%59.6K7.93%1.6M-59.42%490.34K-48.22%417.32K734.52%59.91K-5.83%1.48M909.93%1.21M10,666.93%806K-55.48%7.18K-89.62%1.57M
Total profit 197.75%22.02M151.32%16.48M56.40%20.35M25.95%14.68M268.80%7.4M-151.65%-32.12M-76.88%13.01M-76.84%11.66M13.74%2.01M119.70%62.18M
Less:Income tax cost 91.40%1.36M33.85%3.51M31.86%2.65M25.21%1.68M13.13%708.61K13.93%2.62M51.72%2.01M275.86%1.34M-7.84%626.38K-43.68%2.3M
Net profit 209.02%20.66MFLtoP12.97M60.90%17.69M26.04%13M384.94%6.69MSL-34.74M-79.98%11M-79.36%10.31M27.28%1.38MFLtoP59.87M
Net profit from continuing operation 209.02%20.66M137.34%12.97M60.90%17.69M26.04%13M384.94%6.69M-158.02%-34.74M-79.98%11M-79.36%10.31M27.28%1.38M118.72%59.87M
Less:Minority Profit ---------------------41.74%27.46K-----19.12%19.11K-40.90%6.73K4,627.99%47.14K
Net profit of parent company owners 209.02%20.66M137.31%12.97M60.90%17.69M26.28%13M387.32%6.69M-158.11%-34.76M-79.97%11M-79.39%10.29M28.00%1.37M118.71%59.83M
Earning per share
Basic earning per share 205.65%0.0541136.97%0.034259.73%0.046825.55%0.0344378.38%0.0177-157.99%-0.0925-79.97%0.0293-79.43%0.027427.59%0.0037119.45%0.1595
Diluted earning per share 206.82%0.054137.21%0.034259.93%0.046726.57%0.0343388.89%0.0176-157.62%-0.0919-80.04%0.0292-79.65%0.027124.14%0.0036119.45%0.1595
Other composite income 38.81%-140K-20.35%-228.79K52.03%-190.11K
Other composite income of parent company owners ----38.81%-140K-------------20.35%-228.79K------------52.03%-190.11K
Total composite income 209.02%20.66M136.70%12.83M60.90%17.69M26.04%13M384.94%6.69M-158.59%-34.97M-79.98%11M-79.36%10.31M1.38M118.64%59.68M
Total composite income of parent company owners 209.02%20.66M136.67%12.83M60.90%17.69M26.28%13M387.32%6.69M-158.68%-34.99M-79.97%11M-79.39%10.29M--1.37M118.63%59.64M
Total composite income of minority owners ---------------------41.74%27.46K-----19.12%19.11K--6.73K4,627.99%47.14K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Sigma Certified Public Accountants (Special General Partnership)------Sigma Certified Public Accountants (Special General Partnership)------Sigma Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg